A plaintiff from Texas has sued drug maker Takeda Pharmaceutical for being negligent in informing people about the potential side effects of its diabetes controlling drug ‘’. The lawsuit was filed in Circuit Court of Cooks County, Illinois and the plaintiff was reported as Jeffrey Zurio, a resident of Texas. In the lawsuit filed by the plaintiff it is said that he had been taking the diabetes drug Takeda for more than six years before the federal agency U.S.FDA issued a public notification stating the drug is linked with bladder cancer. The plaintiff also added that he was diagnosed with bladder only a month after the notification was issued by the FDA. The plaintiff brings multiple counts against the defendant Takeda pharmaceuticals including negligence, strict liability, misrepresentations of clinical data, concealment of relevant information and breach of warranties. With this , the plaintiff has sought for compensatory and punitive damages along with an excess of $50,000 for the injuries that he sustained all the way.

Hundreds of Actos lawsuits are still to be observed and heard by the Court and most of them alleged that prolonged use of Actos caused bladder cancer to them and that the company should have adequately informed patients about it. Viewing the growing number of lawsuits the U.S. Judicial Panel on Multi-district Litigation established an Actos MDL to consolidate federal lawsuits involving Actos in the U.S. District Court for the Western District of Louisiana on December 29, 2011.

About the Unsafe Drug Actos

Actos is a prescription drug manufactured and marketed by pharmaceutical giant Takeda Pharmaceuticals. The drug is prescribed to treat the condition of and regulate the glucose levels in the body. The drug is basically a Pioglitazone that is sold as single-ingredient product under the brand-name Actos for the treatment of Type II Diabetes Mellitus in adults.

Some Basic Facts about Actos:

  • The prescription drug Actos is manufactured and marketed by Takeda Pharma one of the drug maker based at North America
  • Reports from federal agency FDA it is estimated that from January 2010 through October 2010, approximately 2.3 million patients filled a prescription for a pioglitazone-containing product.
  • Actos is also sold in combination with metformin and glimepiride
  • The prescription tablet is used along with diet and exercise to regulate the level of blood sugar in adults with type 2 mellitus.

Various warning letter was issued to Takeda Pharmaceuticals over the diabetic drug Actos that were based on various studies that examined and analyzed millions of patients. According to these reports, patients who used Actos for a prolonged period of 12 months or more had a 40 percent increased risk of developing Bladder Cancer.